Dupont Jakob
SEC-identified person · CIK 1553335 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bolt Biotherapeutics, Inc. BOLT | Director | filed 2024 - 2026 |
| Pyxis Oncology, Inc. PYXS | Director | filed 2023 - 2026 |
| Brookline Capital Acquisition Corp. BCACU | Director | filed 2022 - 2023 |
| Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | filed 2020 - 2023 |
| Gossamer Bio, Inc. GOSS | Chief Medical Officer | filed 2019 - 2020 |
| Oncomed Pharmaceuticals Inc OMED | SVP & Chief Medical Officer | filed 2013 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.